{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:52:12Z","timestamp":1777441932454,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.prostaglandins.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T14:02:15Z","timestamp":1428242535000},"page":"115-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT2 receptor"],"prefix":"10.1016","volume":"120","author":[{"given":"Val\u00e9rie","family":"Capra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Carnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosa","family":"Accomazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Fiumicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Brivio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Buccellati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8788-9783","authenticated-orcid":false,"given":"Gianenrico","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0370","first-page":"84","article-title":"Leukotrienes: lipid bioeffectors of inflammatory reactions","volume":"63","author":"Sala","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0375","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbalip.2014.09.002","article-title":"Transcellular biosynthesis of eicosanoid lipid mediators","volume":"1851","author":"Capra","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0380","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1476-5381.1993.tb13943.x","article-title":"Formation of sulphidopeptide-leukotrienes by cell\u2013cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit","volume":"110","author":"Sala","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0385","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/01.CIR.101.12.1436","article-title":"Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness","volume":"101","author":"Sala","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0390","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood.V87.5.1824.1824","article-title":"Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit","volume":"87","author":"Sala","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0395","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1096\/fj.03-0599fje","article-title":"Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes","volume":"18","author":"Di Gennaro","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0400","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/288484a0","article-title":"Leukotrienes are potent constrictors of human bronchi","volume":"288","author":"Dahlen","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0405","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-22","article-title":"Leukotrienes in cardiovascular diseases","volume":"161","author":"Folco","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0410","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.21251","article-title":"Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke","volume":"33","author":"Capra","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0415","first-page":"101","article-title":"Leukotrienes: role in cardiovascular physiology","volume":"18","author":"Letts","year":"1987","journal-title":"Cardiovasc Clin"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0420","first-page":"101","article-title":"Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders","volume":"264","author":"Lefer","year":"1988","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0425","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02912454","article-title":"Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man","volume":"27","author":"Vigorito","year":"1997","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0430","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.110.004184","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions","volume":"63","author":"Back","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0435","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2004.05.003","article-title":"The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues","volume":"103","author":"Norel","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0440","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1365-2222.2012.03982.x","article-title":"Cysteinyl leukotriene receptors, old and new; implications for asthma","volume":"42","author":"Laidlaw","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0445","first-page":"409","article-title":"Effects of leukotrienes C4 and D4 on human isolated saphenous veins","volume":"34","author":"Allen","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0450","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1476-5381.1995.tb16627.x","article-title":"Leukotriene receptors on human pulmonary vascular endothelium","volume":"115","author":"Ortiz","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0455","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1161\/01.CIR.92.11.3304","article-title":"Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells","volume":"92","author":"Datta","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0460","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1073\/pnas.83.7.2204","article-title":"Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils","volume":"83","author":"McIntyre","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0465","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3565(24)36665-0","article-title":"Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism","volume":"281","author":"Pedersen","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0470","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","article-title":"The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm","volume":"10","author":"Zhao","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0475","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1073\/pnas.0601223103","article-title":"Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells","volume":"103","author":"Uzonyi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0480","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1096\/fj.10-177030","article-title":"Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor","volume":"25","author":"Carnini","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0485","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1016\/S0021-9258(19)83778-X","article-title":"High and low molecular weight forms of endothelial cell growth factor","volume":"257","author":"Maciag","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0490","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF02628957","article-title":"Long-term culture of human endothelial cells","volume":"19","author":"Gordon","year":"1983","journal-title":"In Vitro"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0495","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0960-894X(96)00598-7","article-title":"Synthesis and biological evaluation of 14,15-dehydro-LTA(4) analog","volume":"7","author":"Garcia","year":"1997","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0500","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.ATV.16.3.488","article-title":"Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization","volume":"16","author":"Rabiet","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0505","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0510","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1152\/jn.1994.71.6.2463","article-title":"Multifocal spontaneous epileptic activity induced by restricted bicuculline ejection in the piriform cortex of the isolated guinea pig brain","volume":"71","author":"De Curtis","year":"1994","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0515","series-title":"Guide for the care and use of laboratory animals","year":"1996"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0520","doi-asserted-by":"crossref","first-page":"17944","DOI":"10.1074\/jbc.271.30.17944","article-title":"Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes","volume":"271","author":"Sala","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0525","first-page":"E97","article-title":"Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves","volume":"235","author":"DeLean","year":"1978","journal-title":"Am J Physiol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0530","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1098-8823(03)00045-5","article-title":"Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells","volume":"71","author":"Capra","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0535","doi-asserted-by":"crossref","first-page":"22614","DOI":"10.1074\/jbc.M101927200","article-title":"Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function","volume":"276","author":"Mehta","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0540","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(92)90163-7","article-title":"The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors","volume":"70","author":"Ridley","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0545","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq086","article-title":"Role of GTPases in control of microvascular permeability","volume":"87","author":"Spindler","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0550","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.drudis.2010.06.008","article-title":"Label-free whole-cell assays: expanding the scope of GPCR screening","volume":"15","author":"Scott","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0555","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1087057108330115","article-title":"Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity","volume":"14","author":"Peters","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0560","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003495-200161020-00012","article-title":"Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma","volume":"61","author":"Dunn","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0565","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00003495-200363100-00005","article-title":"Pranlukast: a review of its use in the management of asthma","volume":"63","author":"Keam","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0570","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0575","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1161\/01.CIR.97.24.2406","article-title":"Differential leukotriene constrictor responses in human atherosclerotic coronary arteries","volume":"97","author":"Allen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0580","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1006\/bbrc.2001.5695","article-title":"Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells","volume":"287","author":"Kamohara","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0585","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1161\/01.ATV.0000082689.46538.DF","article-title":"Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells","volume":"23","author":"Sjostrom","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0590","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1365-2222.2001.01184.x","article-title":"Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils","volume":"31","author":"Mita","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0595","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/01.ATV.0000082690.23131.CB","article-title":"Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis","volume":"23","author":"Lotzer","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0600","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1161\/01.CIR.0000147775.50954.AA","article-title":"Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure","volume":"110","author":"Hui","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0605","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2353\/ajpath.2008.070834","article-title":"Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury","volume":"172","author":"Jiang","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0610","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/jpet.111.186031","article-title":"A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia\/reperfusion injury and vascular permeability in mice","volume":"339","author":"Ni","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0615","doi-asserted-by":"crossref","first-page":"46129","DOI":"10.1074\/jbc.M407057200","article-title":"Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice","volume":"279","author":"Beller","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0620","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/S0021-9258(18)34575-7","article-title":"Albumin stabilizes leukotriene A4","volume":"257","author":"Fitzpatrick","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0625","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2006.10.065","article-title":"Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia","volume":"412","author":"Fang","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/glia.20588","article-title":"Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation","volume":"56","author":"Huang","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0635","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2006.05.023","article-title":"Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death","volume":"346","author":"Sheng","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0640","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2006.09.057","article-title":"Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression","volume":"350","author":"Wang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0645","first-page":"75","article-title":"Molecular mechanisms of thrombin-induced endothelial cell permeability","volume":"67","author":"Bogatcheva","year":"2002","journal-title":"Biochem"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0650","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/srep03274","article-title":"Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT2 and CysLT1 receptors","volume":"3","author":"Duah","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0655","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1073\/pnas.88.6.2232","article-title":"Inositol trisphosphate receptor: phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles","volume":"88","author":"Ferris","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0660","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcp.2005.10.003","article-title":"CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors","volume":"71","author":"Mamedova","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0665","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.0900071","article-title":"Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists","volume":"184","author":"Woszczek","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0670","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(25)11007-0","article-title":"Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways","volume":"243","author":"Hay","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0675","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1254\/jjp.60.227","article-title":"In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues","volume":"60","author":"Obata","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0680","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0026-895X(24)23228-4","article-title":"A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma","volume":"57","author":"Ravasi","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0685","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/med.20071","article-title":"Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends","volume":"27","author":"Capra","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0690","doi-asserted-by":"crossref","first-page":"e41786","DOI":"10.1371\/journal.pone.0041786","article-title":"Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease","volume":"7","author":"Nobili","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0695","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1189\/jlb.0808476","article-title":"Leukotriene modifiers in the treatment of cardiovascular diseases","volume":"84","author":"Riccioni","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0700","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","article-title":"Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease","volume":"129","author":"Ingelsson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0705","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0090-6980(88)90031-7","article-title":"The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model","volume":"35","author":"Toki","year":"1988","journal-title":"Prostaglandins"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0710","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/cvr\/26.12.1206","article-title":"Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion","volume":"26","author":"Hock","year":"1992","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0715","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-3565(25)11472-9","article-title":"Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury","volume":"260","author":"Hahn","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0720","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1253\/jcj.53.1115","article-title":"Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart","volume":"53","author":"Ito","year":"1989","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0725","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0400235101","article-title":"Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis","volume":"101","author":"Beller","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2015.03.007_bib0730","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2007-07-100453","article-title":"CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells","volume":"110","author":"Jiang","year":"2007","journal-title":"Blood"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:26:15Z","timestamp":1747866375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882315000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":73,"alternative-id":["S1098882315000374"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.03.007","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT2 receptor","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}